ERBB2 and triple-negative breast carcinoma: Notably, WDR62 expression in triple-negative breast cancer (TNBC) was more correlated with PD-L1 expression than Her2 and luminal subtype (Figure 9(d)), in accordance with the above data about WDR62's role in TNBC.